source
- Tiziana Life Sciences CEO Ivor Elrifi boosts stake, buying 321,423 shares at $1 eachTiziana Life Sciences announced that its chief executive officer, Ivor Elrifi, purchased 321,423 common shares of the company on NASDAQ at $1.00 per share. The purchase raises his total holding to…
- Novo Nordisk board members disclose share vesting transactionsNovo Nordisk issued a regulatory announcement on 6 August 2026 detailing share transactions by its board members, executives and related persons, as required by EU market abuse regulation. The fil…